Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 923 | 1,027 | 926 | 869 | 811 |
| Income taxes - deferred | 0 | 0 | 0 | 0 | 61 |
| Accounts receivable | -32 | 72 | -117 | -36 | -67 |
| Other Working Capital | 3,005 | 1,096 | 1,477 | 342 | 966 |
| Other Operating Activity | -8,913 | -7,834 | -6,557 | -7,749 | -6,426 |
| Operating Cash Flow | $-5,018 | $-5,638 | $-4,270 | $-6,574 | $-4,654 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -287 | -24 | -51 | -12 | -123 |
| Net Acquisitions | 0 | 0 | 0 | 0 | 159 |
| Purchase Of Investment | -13,839 | -3,601 | -18,431 | -9,453 | N/A |
| Investing Cash Flow | $-14,127 | $-3,625 | $-18,481 | $-9,465 | $36 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -21 | -34 | -23 | -22 | -13 |
| Common Stock Issued | 18,434 | 1,451 | N/A | N/A | 240 |
| Other Financing Activity | -4 | 0 | 29,980 | 0 | 46 |
| Financing Cash Flow | $18,409 | $1,417 | $29,957 | $-22 | $273 |
| Exchange Rate Effect | 1,167 | -303 | -775 | -235 | 1,086 |
| Beginning Cash Position | 22,672 | 28,943 | 21,552 | 37,848 | 42,252 |
| End Cash Position | 22,553 | 22,672 | 28,943 | 21,552 | 37,551 |
| Net Cash Flow | $-736 | $-7,846 | $7,205 | $-16,061 | $-4,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,018 | -5,638 | -4,270 | -6,574 | -4,654 |
| Capital Expenditure | -287 | -24 | -51 | -12 | -123 |
| Free Cash Flow | -5,306 | -5,663 | -4,321 | -6,587 | -4,777 |